发布求助
文献互助 智能选刊 最新文献

Clinical ovarian cancer and other gynecologic malignancies最新文献

筛选
英文 中文
2022-RA-1294-ESGO Chemosensitivity in vulnerable older patients is unfavorable and highly dependent on the treatment regimen: CA125 elimination rate constant K (KELIM) analysis of the GINECO-ENGOT EWOC-1 trial 易感老年患者的化疗敏感性是不利的，高度依赖于治疗方案:GINECO-ENGOT EWOC-1试验的CA125消除率常数K (KELIM)分析
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.680
O. Colomban, E. Bourbouloux, Marie-Ange Mouret-Renier, D. Lorusso, C. Blonz, A. Savoye, G. Freyer, Margot Noblecourt, M. Gatineau, L. Stefani, L. Gladieff, F. Joly, L. Venat-Bouvet, D. Mollon-Grange, U. Peen, L. Borgato, E. Pujade-Lauraine, B. You, C. Falandry
{"title":"2022-RA-1294-ESGO Chemosensitivity in vulnerable older patients is unfavorable and highly dependent on the treatment regimen: CA125 elimination rate constant K (KELIM) analysis of the GINECO-ENGOT EWOC-1 trial","authors":"O. Colomban, E. Bourbouloux, Marie-Ange Mouret-Renier, D. Lorusso, C. Blonz, A. Savoye, G. Freyer, Margot Noblecourt, M. Gatineau, L. Stefani, L. Gladieff, F. Joly, L. Venat-Bouvet, D. Mollon-Grange, U. Peen, L. Borgato, E. Pujade-Lauraine, B. You, C. Falandry","doi":"10.1136/ijgc-2022-esgo.680","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.680","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85067430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1412-ESGO The association between social deprivation in Northern Ireland and treatment of ovarian cancer 北爱尔兰的社会剥夺与卵巢癌治疗之间的关系
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.710
Josh Courtney Mcmullan, Lisa Rannaghan, L. Simpson, H. Nagar
{"title":"2022-RA-1412-ESGO The association between social deprivation in Northern Ireland and treatment of ovarian cancer","authors":"Josh Courtney Mcmullan, Lisa Rannaghan, L. Simpson, H. Nagar","doi":"10.1136/ijgc-2022-esgo.710","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.710","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"86 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85436929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
2022-RA-882-ESGO Surgical outcome after upper abdominal surgery procedures for ovarian cancer 卵巢癌上腹部手术后的手术结果
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.581
Evelina Karlsson, I. Silins, I. Poromaa, K. Stålberg, M. Lomnytska
{"title":"2022-RA-882-ESGO Surgical outcome after upper abdominal surgery procedures for ovarian cancer","authors":"Evelina Karlsson, I. Silins, I. Poromaa, K. Stålberg, M. Lomnytska","doi":"10.1136/ijgc-2022-esgo.581","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.581","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81842847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1422-ESGO Detailed profiling of the immune microenvironment in ovarian epithelial cancers; relation to tumour characteristics and impact on prognosis 卵巢癌免疫微环境的详细分析与肿瘤特征的关系及对预后的影响
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.712
A. Stout, Natalya Facey, Anjali Bhatnagar, Kirstie Rice, F. Berditchevski, D. Kearns, Amy Metcalf, A. Shaaban, Alaa Elghobashy
{"title":"2022-RA-1422-ESGO Detailed profiling of the immune microenvironment in ovarian epithelial cancers; relation to tumour characteristics and impact on prognosis","authors":"A. Stout, Natalya Facey, Anjali Bhatnagar, Kirstie Rice, F. Berditchevski, D. Kearns, Amy Metcalf, A. Shaaban, Alaa Elghobashy","doi":"10.1136/ijgc-2022-esgo.712","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.712","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"59 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80920017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-276-ESGO Value of surgical cytoreduction for subsequent ovarian cancer relapse in patients previously treated with chemotherapy alone at 1st-relapse: a subanalysis of the DESKTOP III/ENGOT-ov20 trial 在首次复发时单独接受化疗的患者中，手术细胞减少对随后卵巢癌复发的价值:DESKTOP III/ENGOT-ov20试验的亚分析
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.491
C. Fotopoulou, J. Sehouli, I. Vergote, A. Reuss, M. Leheurteur, F. Hilpert, A. Savoye, S. Greggi, Johanna Vernersson, B. Resch, M. Gatineau, J. Levêque, R. Zang, P. Jensen, Jae Wook Kim, Domingo Santiago, F. Raspagliesi, U. Peen, A. Bois, P. Harter
{"title":"2022-RA-276-ESGO Value of surgical cytoreduction for subsequent ovarian cancer relapse in patients previously treated with chemotherapy alone at 1st-relapse: a subanalysis of the DESKTOP III/ENGOT-ov20 trial","authors":"C. Fotopoulou, J. Sehouli, I. Vergote, A. Reuss, M. Leheurteur, F. Hilpert, A. Savoye, S. Greggi, Johanna Vernersson, B. Resch, M. Gatineau, J. Levêque, R. Zang, P. Jensen, Jae Wook Kim, Domingo Santiago, F. Raspagliesi, U. Peen, A. Bois, P. Harter","doi":"10.1136/ijgc-2022-esgo.491","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.491","url":null,"abstract":"double ended needle are used for the technique. Results Patient had optimal debulking surgery and the postoperative course was uneventful. She received adjuvant chemotherapy and is disease free for 24 months. Conclusion Surgical skill development is crucial for reducing postoperative morbidity and to achieve optimal debulking. Due to increased use of staplers for bowel anastomosis in recent decades, hand sewn bowel anastomosis is not practiced regularly. However, hand sewn anastomosis is cost effective and is especially useful in resource limited or emergency setting. ‘Double O’ technique is simpler to use and eliminates many technical nuances described in traditional hand-sewn anastomosis. The technique helps the gynecological oncology surgical trainee to learn and retain the steps due to its simplicity and also helps to overcome the fear of suturing corners in bowel anastomosis during the learning curve.","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"82 9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83222210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
2022-RA-1542-ESGO ‘Things have changed’. Laparoscopic cytoreduction for advanced and recurrent ovarian cancer: The experience of a referral center on 108 patients “一切都变了”。腹腔镜下晚期和复发性卵巢癌的细胞减少:转诊中心108例患者的经验
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.740
M. Ceccaroni, S. Dababou, G. Roviglione, F. Bruni, Martina Venier, R. Clarizia, Carlotta Zorzi, D. Mautone, M. Salgarello, G. Mantovani, L. Driul, S. Gori, S. Uccella
{"title":"2022-RA-1542-ESGO ‘Things have changed’. Laparoscopic cytoreduction for advanced and recurrent ovarian cancer: The experience of a referral center on 108 patients","authors":"M. Ceccaroni, S. Dababou, G. Roviglione, F. Bruni, Martina Venier, R. Clarizia, Carlotta Zorzi, D. Mautone, M. Salgarello, G. Mantovani, L. Driul, S. Gori, S. Uccella","doi":"10.1136/ijgc-2022-esgo.740","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.740","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78815604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-687-ESGO ARTISTRY-7: phase 3, multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68) 2022-RA-687-ESGO artitry -7:耐铂上皮性卵巢癌、输卵管癌或原发性腹膜癌患者的nemvaleukin - alfa联合派姆单抗与化疗的3期多中心研究(GOG-3063;ENGOT-OV68)
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.546
T. Herzog, K. Moore, P. Konstantinopoulos, L. Gilbert, J. Hays, B. Monk, D. O’Malley, J. Barlin, J. Graham, Monali Desai, Yan Wang, Yangchun Du, R. Dalal, R. Coleman, J. Sehouli
{"title":"2022-RA-687-ESGO ARTISTRY-7: phase 3, multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68)","authors":"T. Herzog, K. Moore, P. Konstantinopoulos, L. Gilbert, J. Hays, B. Monk, D. O’Malley, J. Barlin, J. Graham, Monali Desai, Yan Wang, Yangchun Du, R. Dalal, R. Coleman, J. Sehouli","doi":"10.1136/ijgc-2022-esgo.546","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.546","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"142 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90889823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1649-ESGO Mirrors study: a prospective cohort study assessing the feasibility of robotic interval cytoreductive surgery for advanced-stage ovarian cancer 2022-RA-1649-ESGO研究:一项评估机器人间隔期细胞减少手术治疗晚期卵巢癌可行性的前瞻性队列研究
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.765
C. Uwins, A. Tailor, J. Read, J. Crawshaw, Jayanta Chatterjee, P. Ellis, S. Skene, A. Michael, S. Butler-Manuel
{"title":"2022-RA-1649-ESGO Mirrors study: a prospective cohort study assessing the feasibility of robotic interval cytoreductive surgery for advanced-stage ovarian cancer","authors":"C. Uwins, A. Tailor, J. Read, J. Crawshaw, Jayanta Chatterjee, P. Ellis, S. Skene, A. Michael, S. Butler-Manuel","doi":"10.1136/ijgc-2022-esgo.765","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.765","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"60 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85865466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
2022-RA-1409-ESGO Atypical proliferative clear cell tumor originated in endometriosis of the abdominal wall 起源于腹壁子宫内膜异位症的非典型增生性透明细胞瘤
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.709
A. Barrera, Dianelle A Soto Troya, Luis Orlando Puentes Puentes, Maikel Pacheco
{"title":"2022-RA-1409-ESGO Atypical proliferative clear cell tumor originated in endometriosis of the abdominal wall","authors":"A. Barrera, Dianelle A Soto Troya, Luis Orlando Puentes Puentes, Maikel Pacheco","doi":"10.1136/ijgc-2022-esgo.709","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.709","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86653951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1351-ESGO Uterine involvement in epithelial ovarian cancer & its risk factors 上皮性卵巢癌的子宫受累及其危险因素
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.698
N. Zamani, S. Sheikhhasani, Sara Nikfar
{"title":"2022-RA-1351-ESGO Uterine involvement in epithelial ovarian cancer & its risk factors","authors":"N. Zamani, S. Sheikhhasani, Sara Nikfar","doi":"10.1136/ijgc-2022-esgo.698","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.698","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81201138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书